Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
pfizer
46
×
life sciences
national blog main
biotech
boston blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
boston top stories
san francisco top stories
national
boulder/denver blog main
boulder/denver top stories
raleigh-durham blog main
raleigh-durham top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
cancer
startups
bristol-myers squibb
deals
fda
merck
novartis
celgene
investing
amgen
cancer immunotherapy
What
drug
bio
roundup
pfizer
medical
cancer
week
fda
life
science
annual
approved
companies
gene
medicine
new
patients
vaccine
biotech
ceo
company
conference
data
days
help
news
pharmaceutical
therapeutics
today
alnylam
alzheimer’s
announced
blood
clinical
coronavirus
covid
crispr
develop
disease
esmo
Language
unset
unknown
Current search:
pfizer
×
@techcrunch.com
2 years ago
Truveta is making progress towards building a living medical portrait of America
@bgr.com
2 years ago
If you take this popular prescription medicine, stop immediately and read this
@bgr.com
2 years ago
If you take this popular prescription medication, stop right now and call your doctor
@techcrunch.com
2 years ago
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
@engadget.com
3 years ago
Russian, Chinese hackers may have stolen European vaccine data
@bgr.com
3 years ago
Coronavirus vaccinations to start as soon as Monday, but Pfizer drug supply will be limited
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@venturebeat.com
4 years ago
Pfizer launches pilot with home robot Mabu to study patient response to AI
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@techcrunch.com
4 years ago
All that glitters is not gold: How healthtech startups can achieve true value
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@techcrunch.com
5 years ago
Drone delivery startup Zipline launches UAV medical program in Ghana
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@venturebeat.com
6 years ago
AI could help reduce the administrative costs of health care
@SeverineLienard
7 years ago
[#AI] #IBMWatson & Pfizer join forces on cancer drug discovery http://buff.ly/2g78CV3 #BigData #Health… https://twitter.com/i/web/status/805647928715079681
@KirkDBorne
7 years ago
How @Pfizer uses #PredictiveModeling and #BigData science to predict clinical trial risks: https://lnkd.in/e6q99TR #DataScience
@techcrunch.com
8 years ago
IBM, Pfizer launch joint experiment to help measure Parkinson’s symptoms using IoT and analytics